As a parent considering autism interventions for your child, navigating the vast array of treatment options can be overwhelming. Recently, The Los Angeles Times explored the experience of a father and his son with autism, who underwent Transcranial Magnetic Stimulation (TMS) therapy, a type of neuromodulation. This rapidly growing field holds promise for conditions like depression, autism, epilepsy, and Parkinson's disease.
Dr. Christine Conelea, a MnDRIVE Neuromodulation Researcher, emphasized the importance of rigorous research in evaluating the effectiveness of neuromodulation therapies. "Small samples like this aren't good for establishing the benefits of a treatment, conclusively showing safety or demonstrating that an investigational treatment is better than placebo," she cautioned.The article offers valuable guidance for parents and caregivers seeking to evaluate research on neuromodulation therapies, particularly for children. By understanding what to watch for, you can make informed decisions about the best course of treatment for your child.Get Informed. Get Empowered.
Learn more about neuromodulation therapies and how to critically evaluate research to make the best decisions for your child's health. Read the full article at The Los Angeles Times to uncover expert insights and real-life experiences that can inform your journey. experiences that can inform your journey.
